Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)

Dian Wang; Qiang Zhang; Charles D. Blanke; George D. Demetri; Michael C. Heinrich; James C. Watson; John P. Hoffman; Scott Okuno; John M. Kane; Margaret Von Mehren; Burton L. Eisenberg

doi:10.1245/s10434-012-2228-3

Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)

Dian Wang, Qiang Zhang, Charles D. Blanke, George D. Demetri, Michael C. Heinrich, James C. Watson, John P. Hoffman, Scott Okuno, John M. Kane, Margaret Von Mehren, Burton L. Eisenberg

Hematology & Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2420
Number of pages	1
Journal	Annals of surgical oncology
Volume	19
Issue number	7
DOIs	https://doi.org/10.1245/s10434-012-2228-3
State	Published - Jul 2012

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-012-2228-3

Cite this

Wang, D., Zhang, Q., Blanke, C. D., Demetri, G. D., Heinrich, M. C., Watson, J. C., Hoffman, J. P., Okuno, S., Kane, J. M., Von Mehren, M., & Eisenberg, B. L. (2012). Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5). Annals of surgical oncology, 19(7), 2420. https://doi.org/10.1245/s10434-012-2228-3

Erratum : Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5). / Wang, Dian; Zhang, Qiang; Blanke, Charles D. et al.

In: Annals of surgical oncology, Vol. 19, No. 7, 07.2012, p. 2420.

Research output: Contribution to journal › Comment/debate › peer-review

Wang, D, Zhang, Q, Blanke, CD, Demetri, GD, Heinrich, MC, Watson, JC, Hoffman, JP, Okuno, S, Kane, JM, Von Mehren, M & Eisenberg, BL 2012, 'Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)', Annals of surgical oncology, vol. 19, no. 7, pp. 2420. https://doi.org/10.1245/s10434-012-2228-3

Wang D, Zhang Q, Blanke CD, Demetri GD, Heinrich MC, Watson JC et al. Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5). Annals of surgical oncology. 2012 Jul;19(7):2420. doi: 10.1245/s10434-012-2228-3

Wang, Dian ; Zhang, Qiang ; Blanke, Charles D. et al. / Erratum : Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5). In: Annals of surgical oncology. 2012 ; Vol. 19, No. 7. pp. 2420.

@article{330adcd0d60b4c6086f08ee93c287e13,

title = "Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)",

author = "Dian Wang and Qiang Zhang and Blanke, {Charles D.} and Demetri, {George D.} and Heinrich, {Michael C.} and Watson, {James C.} and Hoffman, {John P.} and Scott Okuno and Kane, {John M.} and {Von Mehren}, Margaret and Eisenberg, {Burton L.}",

year = "2012",

month = jul,

doi = "10.1245/s10434-012-2228-3",

language = "English (US)",

volume = "19",

pages = "2420",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "7",

}

TY - JOUR

T1 - Erratum

T2 - Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)

AU - Wang, Dian

AU - Zhang, Qiang

AU - Blanke, Charles D.

AU - Demetri, George D.

AU - Heinrich, Michael C.

AU - Watson, James C.

AU - Hoffman, John P.

AU - Okuno, Scott

AU - Kane, John M.

AU - Von Mehren, Margaret

AU - Eisenberg, Burton L.

PY - 2012/7

Y1 - 2012/7

UR - http://www.scopus.com/inward/record.url?scp=84865152211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865152211&partnerID=8YFLogxK

U2 - 10.1245/s10434-012-2228-3

DO - 10.1245/s10434-012-2228-3

M3 - Comment/debate

AN - SCOPUS:84865152211

VL - 19

SP - 2420

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 7

ER -

Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this